Clinical Trials Sponsored by Kyowa Hakko Kirin Pharma, Inc.
Total 94 results
-
Kyowa Hakko Kirin Pharma, Inc.TerminatedAcute Myelogenous Leukemia (AML)United States
-
Kyowa Hakko Kirin Pharma, Inc.TerminatedColorectal CancerUnited States
-
Kyowa Hakko Kirin Pharma, Inc.TerminatedBreast CancerUnited States
-
Kyowa Hakko Kirin Pharma, Inc.Completed
-
Kyowa Hakko Kirin Pharma, Inc.TerminatedNeoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmUnited States
-
Kyowa Hakko Kirin Pharma, Inc.Completed
-
Kyowa Hakko Kirin Pharma, Inc.TerminatedMultiple MyelomaUnited States
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Kyowa Hakko Kirin Pharma, Inc.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
Kyowa Hakko Kirin Pharma, Inc.CompletedAlzheimer's DiseaseBelgium, Finland, Netherlands, Serbia, Sweden
-
Kyowa Hakko Kirin Pharma, Inc.CompletedParkinson's DiseaseUnited States
-
Kyowa Hakko Kirin Pharma, Inc.CompletedHepatic ImpairmentUnited States
-
Kyowa Hakko Kirin Pharma, Inc.Teva PharmaCompletedAdenocarcinoma of the Pancreas | Solid Tumour | Adenocarcinoma of the Colorectal
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.Completed
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedMultiple MyelomaUnited States, Philippines, United Kingdom
-
Kyowa Hakko Kirin UK, Ltd.CompletedParkinson's DiseaseUnited Kingdom
-
Kyowa Hakko Kirin UK, Ltd.CompletedMultiple Myeloma | Chronic Lymphocytic Leukaemia | B-cell Non-Hodgkin's LymphomaUnited Kingdom
-
Kyowa Kirin, Inc.Kyowa Hakko Kirin UK, Ltd.CompletedParkinson's DiseaseUnited States
-
Kyowa Hakko Kirin UK, Ltd.CompletedCongenital Antithrombin DeficiencyFrance, Germany, Italy, Sweden, United Kingdom
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Seoul National University HospitalKyowa Hakko Kirin Pharma, Inc.; Jeil-Kirin Pharmaceutical Inc.CompletedHealthyKorea, Republic of
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.Completed
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.WithdrawnModerate to Severe Plaque PsoriasisChina
-
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.CompletedHyperparathyroidism; Secondary, RenalChina
-
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.CompletedImmune ThrombocytopeniaChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.CompletedSecondary HyperparathyroidismChina, Hong Kong, Korea, Republic of, Taiwan
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
MEI Pharma, Inc.Kyowa Kirin, Inc.Withdrawn
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Korea, Republic of, Japan, Ireland, United Kingdom, France, Italy
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-Linked HypophosphatemiaKorea, Republic of, Canada, United States, Australia, Japan, United Kingdom, Sweden
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaNetherlands, United States, United Kingdom, France
-
Kyowa Kirin, Inc.RecruitingDiabetic Macular Edema (DME)United States, Japan, Korea, Republic of, Australia
-
Kyowa Kirin, Inc.Active, not recruitingCutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, RelapsedUnited States, United Kingdom, Spain, France, Italy
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Kyowa Kirin, Inc.CompletedHepatic ImpairmentUnited States
-
Kyowa Kirin, Inc.CompletedHealthy Male SubjectsUnited States
-
Kyowa Kirin, Inc.CompletedParkinson's DiseaseUnited States
-
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.CompletedImmune Thrombocytopenia (ITP)China
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Korea, Republic of, Canada, Japan, France, Denmark
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedAtopic DermatitisUnited States, Canada, Germany, Japan
-
Kyowa Kirin, Inc.RecruitingGastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Kyowa Kirin, Inc.RecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States, Japan, Korea, Republic of, Australia
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Kyowa Kirin, Inc.Completed
-
Kyowa Kirin, Inc.CompletedTumor Induced Osteomalacia (TIO) | Epidermal Nevus Syndrome (ENS)United States